Find out more about how GLP-1RAs are associated with a reduced risk of aneurysmal rupture in high-risk patient populations.

Immune checkpoint inhibitors (ICIs) have revolutionized the care of patients with cancer, but use among hospitalized patients is controversial as a result of questionable benefit and high costs. To ...

This retrospective study analyzes the clinical presentation, diagnosis, management, and outcomes of 201 patients with intracranial suppurations at Donka National Hospital in Guinea. The authors report ...

Prescriptions of glucagon-like peptide-1 receptor agonists (GLP-1RAs) are associated with a reduced risk of aneurysmal rupture in patients with type 2 diabetes and unruptured intracranial aneurysms, ...